Jubilant Cadista Pharmaceuticals, Inc. Recall: BuPROPion Hydrochloride Extended-release Ta
Jubilant Cadista Pharmaceuticals, Inc. Recall: BuPROPion Hydrochloride Extended-release Ta is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Jubilant Cadista Pharmaceuticals, Inc.; Product: BuPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, packaged in a) 60-count bottle
| Recalling firm | Jubilant Cadista Pharmaceuticals, Inc. |
|---|---|
| Product | BuPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, packaged in a) 60-count bottles (NDC 59746-316-60) and b) 100-count bottles (NDC 59746-316-01), Rx only, Manufactured by: Julibant Life Sciences Ltd., Roorkee-247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, USA. |
| Reason for recall | Failed Impurities/Degradation Specifications: high out of specification results for one of the known degradation products, m-chlorobenzoic acid. |
| Classification | Class III (least serious — unlikely to cause adverse health consequences) |
| Status | Terminated |
| Distribution | Nationwide in the USA |
| Recall initiated | 20160408 |
| Recall number | D-0670-2017 |
| Category | drug |
| State | MD |
| Country | United States |
$29/mo
Try RecallGuard →